Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Obstructive Lung Diseases

  Free Subscription


1 Allergy
1 Am J Respir Cell Mol Biol
2 Am J Respir Crit Care Med
4 Chest
4 Eur Respir J
1 J Allergy Clin Immunol
8 J Asthma
1 J Investig Allergol Clin Immunol
1 J Pediatr
1 Minerva Pediatr (Torino)
1 Pediatr Allergy Immunol
14 Pediatr Pulmonol
4 PLoS One
7 Respir Res
1 Rev Mal Respir

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. MISHRA A, Majid D, Kandikattu HK, Yadavalli CS, et al
    Role of IL-18 transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma.
    Allergy. 2021 Nov 20. doi: 10.1111/all.15180.
    PubMed         Abstract available

    Am J Respir Cell Mol Biol

  2. WRENNALL JA, Ahmad S, Worthington EN, Wu T, et al
    A SPLUNC1 Peptidomimetic Inhibits Orai1 and Reduces Inflammation in a Murine Allergic Asthma Model.
    Am J Respir Cell Mol Biol. 2021 Nov 22. doi: 10.1165/rcmb.2020-0452.
    PubMed         Abstract available

    Am J Respir Crit Care Med

  3. CARR TF, Kraft M
    Gaining Insights into Asthma-related COVID-19 Risk.
    Am J Respir Crit Care Med. 2021 Nov 23. doi: 10.1164/rccm.202111-2473.

  4. TIOTIU A, Badi Y, Kermani NZ, Sanak M, et al
    Association of Differential Mast Cell Activation to Granulocytic Inflammation in Severe Asthma.
    Am J Respir Crit Care Med. 2021 Nov 23. doi: 10.1164/rccm.202102-0355.
    PubMed         Abstract available


  5. PISTELLI F, Carrozzi L
    Slow Is Better Than Fast?: Usefulness of FEV1/Slow Vital Capacity <0.7 in the Identification of Asymptomatic Ever Smokers at Risk for COPD.
    Chest. 2021;160:7-8.

  6. FORTIS S, Comellas AP, Bhatt SP, Hoffman EA, et al
    Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
    Chest. 2021;160:94-103.
    PubMed         Abstract available

    Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
    Chest. 2021;160:104-113.
    PubMed         Abstract available

  8. CHONG WH, Saha B, Ibrahim A, Smith TC, et al
    Dyspnea in a 57-Year-Old Man With Recent Viral Illness.
    Chest. 2021;160:e19-e24.
    PubMed         Abstract available

    Eur Respir J

  9. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
    Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
    Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
    PubMed         Abstract available

    Food for thought: why is there more airway smooth muscle in asthma?
    Eur Respir J. 2021;58.

    Asthma, COPD and their overlap: coexistence or something more?
    Eur Respir J. 2021;58.

  12. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
    A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
    Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.

    J Allergy Clin Immunol

  13. OGBOGU PU, Matsui EC, Apter AJ
    COVID-19, Health Disparities, and What the Allergist-Immunologist Can Do.
    J Allergy Clin Immunol. 2021 Sep 23. pii: S0091-6749(21)01447.

    J Asthma

  14. RODRIGUEZ-MARTINEZ CE, Sossa-Briceno MP, Garcia-Marcos L
    Use of inhaled corticosteroids on an intermittent or as-needed basis in pediatric asthma: a systematic review of the literature.
    J Asthma. 2021 Nov 26:1-12. doi: 10.1080/02770903.2021.2008430.
    PubMed         Abstract available

  15. RODRIGUEZ-MARTINEZ CE, Sinha IP, Whittaker E, Nagakumar P, et al
    Nebulization procedures for children with unknown viral status during the COVID-19 pandemic.
    J Asthma. 2021;58:1597-1598.
    PubMed         Abstract available

  16. VAZQUEZ-NAVA F, Vazquez-Rodriguez EM, Vazquez-Rodriguez CF, Betancourt NVO, et al
    Risk factors of non-adherence to guidelines for the prevention of COVID-19 among young adults with asthma in a region with a high risk of a COVID-19 outbreak.
    J Asthma. 2021;58:1630-1636.
    PubMed         Abstract available

  17. HUANG J, Yang X, Fan F, Hu Y, et al
    Outdoor air pollution and the risk of asthma exacerbations in single lag0 and lag1 exposure patterns: a systematic review and Meta-analysis.
    J Asthma. 2021 Nov 22:1-17. doi: 10.1080/02770903.2021.2008429.
    PubMed         Abstract available

  18. MORALES-ROMERO J, Bedolla-Barajas M
    Asthma is not a Risk Factor for Severity of SARS-CoV-2 Infection in the Mexican Population.
    J Asthma. 2021 Nov 24:1-14. doi: 10.1080/02770903.2021.2010745.
    PubMed         Abstract available

  19. LAM RW, Inselman JW, Jeffery MM, Maddux JT, et al
    Asthma biologic trial eligibility and real-world outcomes in the United States.
    J Asthma. 2021 Nov 24:1-12. doi: 10.1080/02770903.2021.2010749.
    PubMed         Abstract available

  20. ROGERSON CM, He T, Rowan C, Tu W, et al
    Ten Year Trends in Hospital Encounters for Pediatric Asthma: An Indiana Experience.
    J Asthma. 2021 Nov 24:1-11. doi: 10.1080/02770903.2021.2010750.
    PubMed         Abstract available

  21. KAUR S, Rosenstreich D, Cleven KL, Spivack S, et al
    Severe Asthma in Adult, Inner-city predominantly African-American and Latinx Population: Demographic, Clinical and Phenotypic Characteristics.
    J Asthma. 2021 Nov 25:1-15. doi: 10.1080/02770903.2021.2010748.
    PubMed         Abstract available

    J Investig Allergol Clin Immunol

  22. VALERO A, Molina J, Nuevo J, Simon S, et al
    Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain.
    J Investig Allergol Clin Immunol. 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
    PubMed         Abstract available

    J Pediatr

  23. CARPENTER LM, Weinman JP, Aleksanyan Y, Mizoue AK, et al
    Stevens-Johnson Syndrome in Children: Consider Monitoring for Bronchiolitis Obliterans.
    J Pediatr. 2021;236:307-311.
    PubMed         Abstract available

    Minerva Pediatr (Torino)

  24. LI S, Mei Q, Qian D, Huang X, et al
    Salbutamol combined with budesonide in treatment of pediatric bronchial asthma and its effect on eosinophils.
    Minerva Pediatr (Torino). 2021;73:215-221.
    PubMed         Abstract available

    Pediatr Allergy Immunol

  25. OWORA AH, Tepper RS, Ramsey CD, Chan-Yeung M, et al
    Transitions between alternating childhood allergy sensitization - current asthma states: a retrospective cohort analysis.
    Pediatr Allergy Immunol. 2021 Nov 19. doi: 10.1111/pai.13699.
    PubMed         Abstract available

    Pediatr Pulmonol

  26. ROTULO GA, Casalini E, Brisca G, Piccotti E, et al
    Unexpected peak of bronchiolitis requiring oxygen therapy in February 2020: Could an undetected SARS-CoV2-RSV co-infection be the cause?
    Pediatr Pulmonol. 2021;56:1803-1805.

  27. PAPADAKI M, Marmarinos A, Tsolia M, Gourgiotis D, et al
    Cathelicidin levels in nasal secretions are associated with the severity of acute bronchiolitis.
    Pediatr Pulmonol. 2021;56:1673-1680.
    PubMed         Abstract available

  28. SIRAJ S, Stark W, McKinley SD, Morrison JM, et al
    The bronchiolitis severity score: An assessment of face validity, construct validity, and interobserver reliability.
    Pediatr Pulmonol. 2021;56:1739-1744.
    PubMed         Abstract available

  29. YUAN J, Liu L, Zhou W, Tong X, et al
    Plastic bronchitis in a toddler with a history of prematurity.
    Pediatr Pulmonol. 2021 Feb 1. doi: 10.1002/ppul.25290.

  30. HINDS DM, Bloom JL, Cooper JC, Dutmer CM, et al
    Pulmonary eosinophilic vasculitis with granulomas and benralizumab in children.
    Pediatr Pulmonol. 2021;56:1789-1792.

  31. LAFONT M, Morin C, Arrouy A, Rabeau A, et al
    Pediatrician intervention impacts parental smoking in cystic fibrosis, diabetes, and bronchiolitis.
    Pediatr Pulmonol. 2021;56:1716-1723.
    PubMed         Abstract available

  32. SIDHU ST, Morphew T, Galant SP
    Normal growth variance by Z scores should be considered when interpreting the growth inhibitory effect of inhaled corticosteroids.
    Pediatr Pulmonol. 2021;56:1464-1470.
    PubMed         Abstract available

  33. SHMUELI E, Goldberg O, Mei-Zahav M, Stafler P, et al
    Risk factors for respiratory syncytial virus bronchiolitis hospitalizations in children with chronic diseases.
    Pediatr Pulmonol. 2021;56:2204-2211.
    PubMed         Abstract available

  34. KOUIS P, Michaelidou E, Kinni P, Michanikou A, et al
    Pediatric asthma symptom control during lockdown for the COVID-19 pandemic in Spring 2020: A prospective community-based study in Cyprus and Greece.
    Pediatr Pulmonol. 2021 Nov 24. doi: 10.1002/ppul.25765.
    PubMed         Abstract available

  35. LAVIE M, Maymon D, Diamant N, Cahal M, et al
    Respiratory syncytial virus bronchiolitis among refugees and asylum seekers from war-torn countries.
    Pediatr Pulmonol. 2021;56:2888-2892.
    PubMed         Abstract available

  36. MITRI EJ, Zheng DX, Garg V, Crifase CC, et al
    Blood eosinophils, specific immunoglobulin E, and bronchiolitis severity.
    Pediatr Pulmonol. 2021;56:2997-3004.
    PubMed         Abstract available

  37. JERKIC SP, Koc-Gunel S, Herrmann E, Kriszeleit L, et al
    Long-term course of bronchial inflammation and pulmonary function testing in children with postinfectious bronchiolitis obliterans.
    Pediatr Pulmonol. 2021;56:2966-2972.
    PubMed         Abstract available

  38. BEN-DAVID Y, Bentur L, Gur M, Ilivitzki A, et al
    Reverse butterfly pattern image with eosinophilia: Effective treatment with benralizumab-A case report.
    Pediatr Pulmonol. 2021;56:2736-2739.
    PubMed         Abstract available

  39. PAPOFF P, Caresta E, Luciani S, Pierangeli A, et al
    The starting rate for high-flow nasal cannula oxygen therapy in infants with bronchiolitis: Is clinical judgment enough?
    Pediatr Pulmonol. 2021 Apr 30. doi: 10.1002/ppul.25439.
    PubMed         Abstract available

    PLoS One

  40. HALNER A, Beer S, Pullinger R, Bafadhel M, et al
    Predicting treatment outcomes following an exacerbation of airways disease.
    PLoS One. 2021;16:e0254425.
    PubMed         Abstract available

  41. GILLENWATER LA, Helmi S, Stene E, Pratte KA, et al
    Multi-omics subtyping pipeline for chronic obstructive pulmonary disease.
    PLoS One. 2021;16:e0255337.
    PubMed         Abstract available

  42. NOORT BAC, van der Vaart T, Ahaus K
    Orchestration versus bookkeeping: How stakeholder pressures drive a healthcare purchaser's institutional logics.
    PLoS One. 2021;16:e0258337.
    PubMed         Abstract available

  43. RORTH R, Clausen MF, Fosbol EL, Mogensen UM, et al
    Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
    PLoS One. 2021;16:e0255364.
    PubMed         Abstract available

    Respir Res

  44. SINGH R, Belchamber KBR, Fenwick PS, Chana K, et al
    Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD.
    Respir Res. 2021;22:113.
    PubMed         Abstract available

  45. ZHANG WZ, Hoffman KL, Schiffer KT, Oromendia C, et al
    Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
    Respir Res. 2021;22:126.
    PubMed         Abstract available

  46. PRATTE KA, Curtis JL, Kechris K, Couper D, et al
    Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Respir Res. 2021;22:127.
    PubMed         Abstract available

  47. SINGH D, Criner GJ, Dransfield MT, Halpin DMG, et al
    InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
    Respir Res. 2021;22:130.
    PubMed         Abstract available

  48. HEALY C, Munoz-Wolf N, Strydom J, Faherty L, et al
    Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.
    Respir Res. 2021;22:133.
    PubMed         Abstract available

  49. GLOECKL R, Schneeberger T, Leitl D, Reinold T, et al
    Whole-body vibration training versus conventional balance training in patients with severe COPD-a randomized, controlled trial.
    Respir Res. 2021;22:138.
    PubMed         Abstract available

  50. MAJORSKI DS, Magnet FS, Thilemann S, Schmoor C, et al
    Portable NIV for patients with moderate to severe COPD: two randomized crossover trials.
    Respir Res. 2021;22:123.
    PubMed         Abstract available

    Rev Mal Respir

  51. RAHERISON-SEMJEN C, Guilleminault L, Billiart I, Chenivesse C, et al
    [Update of the 2021 recommendations for the management and follow-up of adult asthmatic patients under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version].
    Rev Mal Respir. 2021 Nov 16. pii: S0761-8425(21)00332.

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.